Please login to the form below

Not currently logged in
Email:
Password:

GSK’s finance SVP joins Parexel International

Simon Harford becomes chief financial officer

Pharmaceutical services provider Parexel International has appointed Simon Harford as chief financial officer and senior vice president from 1 June.

Harford joins from GlaxoSmithKline, where he most recently served as senior vice president of finance, based at the pharma firm's global headquarters in the UK.

Prior to joining GSK in 2009, Harford served as group vice president and controller at cosmetics firm Avon, having previously spent two decades at Eli Lilly in a number of roles including chief financial officer for its EMEA operations.

Josef von Rickenbach, chairman and chief executive of Parexel, said: “Simon brings to Parexel more than three decades of global financial management and investor relations experience in the pharmaceutical industry.

“Simon's leadership will strengthen our ability to accelerate growth and improve profitability as we implement our corporate strategy.”

7th March 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics